Cynosure has introduced Cellulaze Cellulite Laser Workstation, a minimally invasive surgical device, designed to reduce cellulite by restoring the normal structure of the skin and underlying connective tissue.
In the CE Mark certified Cellulaze procedure, which is performed under a local anesthetic, the physician inserts a small cannula a narrow tube the size of the tip of a pen under the skin.
Cynosure‘s proprietary SideLight 3D side-firing technology directs controlled, laser thermal energy to the treatment zones, the buttocks and thighs.
The Cellulaze laser is designed to diminish the lumpy pockets of fat, release the areas of skin depression and increase the elasticity and thickness of the skin in just one treatment.
Cynosure president and CEO Michael Davin said unlike the non-invasive treatment approaches that aim to temporarily treat the appearance of cellulite, Cellulaze uses a three-dimensional approach to directly target the subdermal structure that forms the foundation of cellulite.
The US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for Cellulaze, and nearly 100 patients have been treated as part of a clinical IDE study.